Patents by Inventor Connie L. Erickson-Miller

Connie L. Erickson-Miller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CANCER TREATMENT METHOD
    Publication number: 20190008855
    Abstract: Invented is a method of treating cancer or a pre-cancerous syndrome in a mammal, including a human, in need thereof which comprises the administration of an effective amount of a non-peptide thrombopoietin (TPO) receptor agonist to such mammal, suitably a human.
    Type: Application
    Filed: September 17, 2018
    Publication date: January 10, 2019
    Applicant: NOVARTIS AG
    Inventor: Connie L. Erickson-Miller
  • METHODS FOR TREATING DEGENERATIVE DISEASES/INJURIES
    Publication number: 20180000785
    Abstract: Invented is a method of treating degenerative diseases/injuries, in a mammal, including a human, in need thereof which comprises the administration of a therapeutically effective amount of a non-peptide TPO receptor agonist to such mammal.
    Type: Application
    Filed: September 19, 2017
    Publication date: January 4, 2018
    Inventors: Connie L. Erickson-Miller, Julian Jenkins
  • CANCER TREATMENT METHOD
    Publication number: 20170290826
    Abstract: Invented is a method of treating cancer or a pre-cancerous syndrome in a mammal, including a human, in need thereof which comprises the administration of an effective amount of a non-peptide thrombopoietin (TPO) receptor agonist to such mammal, suitably a human.
    Type: Application
    Filed: June 27, 2017
    Publication date: October 12, 2017
    Applicant: NOVARTIS AG
    Inventor: Connie L. ERICKSON-MILLER
  • METHODS FOR TREATING DEGENERATIVE DISEASES/INJURIES
    Publication number: 20160287560
    Abstract: Invented is a method of treating degenerative diseases/injuries, in a mammal, including a human, in need thereof which comprises the administration of a therapeutically effective amount of a non-peptide TPO receptor agonist to such mammal.
    Type: Application
    Filed: June 14, 2016
    Publication date: October 6, 2016
    Applicant: Novartis AG
    Inventors: Connie L. Erickson-Miller, Julian Jenkins
  • CANCER TREATMENT METHOD
    Publication number: 20160235712
    Abstract: Invented is a method of treating cancer or a pre-cancerous syndrome in a mammal, including a human, in need thereof which comprises the administration of an effective amount of a non-peptide thrombopoietin (TPO) receptor agonist to such mammal, suitably a human.
    Type: Application
    Filed: March 7, 2016
    Publication date: August 18, 2016
    Applicant: NOVARTIS AG
    Inventor: Connie L Erickson-Miller
  • METHODS OF TREATING DEGENERATIVE DISEASES/INJURIES
    Publication number: 20160101084
    Abstract: Invented is a method of treating degenerative diseases/injuries, in a mammal, including a human, in need thereof which comprises the administration of a therapeutically effective amount of a non-peptide TPO receptor agonist to such mammal.
    Type: Application
    Filed: December 21, 2015
    Publication date: April 14, 2016
    Inventors: Connie L. Erickson-Miller, Julian Jenkins
  • Methods for Treating Degenerative Diseases/Injuries
    Publication number: 20140275193
    Abstract: Invented is a method of treating degenerative diseases/injuries, in a mammal, including a human, in need thereof which comprises the administration of a therapeutically effective amount of a non-peptide TPO receptor agonist to such mammal.
    Type: Application
    Filed: June 2, 2014
    Publication date: September 18, 2014
    Inventors: Connie L. ERICKSON-MILLER, Julian JENKINS
  • CANCER TREATMENT METHOD
    Publication number: 20140275107
    Abstract: Invented is a method of treating cancer or a pre-cancerous syndrome in a mammal, including a human, in need thereof which comprises the administration of an effective amount of a non-peptide thrombopoietin (TPO) receptor agonist to such mammal, suitably a human.
    Type: Application
    Filed: May 30, 2014
    Publication date: September 18, 2014
    Applicant: GlaxoSmithKline LLC
    Inventor: Connie L. ERICKSON-MILLER
  • METHODS FOR TREATING DEGENERATIVE DISEASES/INJURIES
    Publication number: 20140100258
    Abstract: Invented is a method of treating cardiovascular disease/injury, in a mammal, including a human, in need thereof which comprises the administration of a therapeutically effective amount of a non-peptide TPO receptor agonist to such mammal.
    Type: Application
    Filed: December 9, 2013
    Publication date: April 10, 2014
    Applicant: GlaxoSmithKline LLC
    Inventors: Connie L. ERICKSON-MILLER, Julian JENKINS
  • CANCER TREATMENT METHOD
    Publication number: 20140038982
    Abstract: Invented is a method of treating cancer or a pre-cancerous syndrome in a mammal, including a human, in need thereof which comprises the administration of an effective amount of a non-peptide thrombopoietin (TPO) receptor agonist to such mammal, suitably a human.
    Type: Application
    Filed: May 31, 2013
    Publication date: February 6, 2014
    Applicant: GlaxoSmithKline LLC
    Inventor: Connie L. ERICKSON-MILLER
  • Methods of administration of thrombopoietin agonist compounds
    Patent number: 8609693
    Abstract: The embodiments provide methods of administering a high dose or a loading dose of a TPO modulator to a subject. The embodiments further provide methods of treating thrombocytopenia and/or neutropenia in a subject. Additionally, the embodiments further provide methods of increasing platelet production and/or enhancing the number of peripheral blood stem cells in a subject.
    Type: Grant
    Filed: May 27, 2010
    Date of Patent: December 17, 2013
    Assignee: GlaxoSmithKline LLC
    Inventors: Connie L. Erickson-Miller, Julian Jenkins
  • Thrombopoietin receptor agonist (TpoRA) kills acute human myeloid leukemia cells
    Patent number: 8530508
    Abstract: The present invention provides methods of inhibiting human myeloid leukemia cell growth and proliferation by administering a thrombopoietin receptor agonist (TpoRA), a derivative, or variant thereof, to an individual with AML.
    Type: Grant
    Filed: October 8, 2008
    Date of Patent: September 10, 2013
    Assignee: GlaxoSmithKline LLC
    Inventors: Alan Gewirtz, Anna Kalota, Connie L. Erickson-Miller
  • Method of treating thrombocytopenia
    Patent number: 8476249
    Abstract: Invented is a method of treating thrombocytopenia in a human, in need thereof which comprises the in vivo administration of a therapeutically effective amount of a peptide or a non-peptide TPO receptor agonist and an anti-clotting agent or agents, and optional further active ingredients, to such human.
    Type: Grant
    Filed: May 6, 2010
    Date of Patent: July 2, 2013
    Assignee: GlaxoSmithKline LLC
    Inventors: Connie L. Erickson-Miller, Michael Arning
  • Sialoadhesin factor-2 antibodies
    Patent number: 8207305
    Abstract: Monoclonal antibodies have been generated that bind to human sialoadhesion factor-2. These antibodies are useful as diagnostic and therapeutic reagents.
    Type: Grant
    Filed: May 29, 2009
    Date of Patent: June 26, 2012
    Assignee: The John Hopkins University
    Inventors: Julie A. Abrahamson, Connie L. Erickson-Miller, Kristine K. Kikly, Bruce Bochner, Robert Schleimer, T. Esra Nutku
  • METHOD OF TREATING THROMBOCYTOPENIA
    Publication number: 20120149749
    Abstract: Invented is a method of treating thrombocytopenia in a human in need thereof which comprises the administration of a therapeutically effective amount of a 3?-{N?-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2?-hydroxybiphenyl-3-carboxylic acid to such human.
    Type: Application
    Filed: October 14, 2009
    Publication date: June 14, 2012
    Inventors: Michael Arning, Manuel Carlos Alves-Aivado, Roya Behbahani, Yanli Deng, Connie L. Erickson-Miller, Sophia M. Goodison, Julian Jenkins, Shivakumar G. Kapsi, Bhabita Mayer, Francis Xavier Muller, Bin Peng, Teresa S. Sellers, Nicole Lee Stone, Dickens Theodore, Dennis R. Williams, Mary Beth Wire
  • Methods of use of sialoadhesin factor-2 antibodies
    Patent number: 8197811
    Abstract: Monoclonal antibodies have been generated that bind to human sialoadhesion factor-2. These antibodies are useful as diagnostic and therapeutic reagents.
    Type: Grant
    Filed: January 14, 2011
    Date of Patent: June 12, 2012
    Assignee: The Johns Hopkins University
    Inventors: Julie A. Abrahamson, Connie L. Erickson-Miller, Kristine Kay Kikly, Bruce Scott Bochner, Robert Schleimer, T. Esra Nutku
  • Methods of Administration of Thrombopoietin Agonist Compounds
    Publication number: 20120064036
    Abstract: The embodiments provide methods of administering a high dose or a loading dose of a TPO modulator to a subject. The embodiments further provide methods of treating thrombocytopenia and/or neutropenia in a subject. Additionally, the embodiments further provide methods of increasing platelet production and/or enhancing the number of peripheral blood stem cells in a subject.
    Type: Application
    Filed: May 27, 2010
    Publication date: March 15, 2012
    Inventors: Connie L. Erickson-Miller, Julian Jenkins
  • METHOD OF TREATING THROMBOCYTOPENIA
    Publication number: 20120052055
    Abstract: Invented is a method of treating thrombocytopenia in a human, in need thereof which comprises the in vivo administration of a therapeutically effective amount of a peptide or a non-peptide TPO receptor agonist and an anti-clotting agent or agents, and optional further active ingredients, to such human.
    Type: Application
    Filed: May 6, 2010
    Publication date: March 1, 2012
    Applicant: Glaxosmithkline LLC
    Inventors: Connie L. Erickson-Miller, Michael Arning
  • Method of treating viral diseases with combinations of TPO receptor agonist and anti-viral agents
    Publication number: 20120020923
    Abstract: Invented is a method of treating viral diseases, particularly hepatitis C, in a human, in need thereof which comprises the administration of a combination of therapeutically active agents selected from a TPO receptor agonist and an antiviral therapy selected from: an alpha interferon, ribavirin, a ribavirin analog and an HCV antiviral to such human.
    Type: Application
    Filed: July 26, 2011
    Publication date: January 26, 2012
    Inventors: Connie L. Erickson-Miller, Julian Jenkins, Dickens Theodore
  • METHODS OF USE OF SIALOADHESIN FACTOR-2 ANTIBODIES
    Publication number: 20110217319
    Abstract: Monoclonal antibodies have been generated that bind to human sialoadhesion factor-2.
    Type: Application
    Filed: January 14, 2011
    Publication date: September 8, 2011
    Applicant: THE JOHNS HOPKINS UNIVERSITY
    Inventors: Julie A. Abrahamson, Connie L. Erickson-Miller, Kristine K. Kikly, Bruce Bochner, Robert Schleimer, T. Esra Nutku